Endometrial adenosquamous carcinoma

MONDO:0003556

A rare endometrial carcinoma characterized by the presence of both malignant glandular and malignant squamous cellular components.

Also known as: endometrial adenosquamous carcinoma, endometrium adenosquamous carcinoma, adenosquamous carcinoma of the endometrium, endometrial adenosquamous cancer

2849 clinical trials for this condition and its sub-types, 2 tagged with Endometrial adenosquamous carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Adenosquamous carcinoma (45) ↑ Endometrial squamous cell carcinoma (2)

Including sub-types (2849) Tagged with Endometrial adenosquamous carcinoma (2)

Not yet finished but already full! 1 Completed 1

Could a cancer drug shrink endometrial tumors?

Disease control Completed

This phase 2 trial tested the drug cabozantinib in 102 women with endometrial cancer that had returned or spread. The drug works by blocking enzymes that help tumors grow and by cutting off their blood supply. Researchers measured how many patients saw their tumors shrink or stop…

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC

Endometrial adenosquamous carcinoma

Where it sits in the disease tree

Could a cancer drug shrink endometrial tumors?